Curaleaf Holdings (CURLF) Receivables (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Receivables of $81.4 million for Q4 2025, up 18.44% year-on-year from $68.8 million in Q4 2024, and up 18.44% on a QoQ basis from $68.8 million in Q4 2024.

Curaleaf Holdings (CURLF) Receivables (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Receivables for 7 consecutive years, with $81.4 million the latest figure, recorded in Q4 2025.

  • Quarterly Receivables rose 18.44% year-over-year to $81.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $81.4 million (up 18.44% YoY) and the FY2025 annual result came in at $81.4 million, up 15.03% from the prior year.
  • Receivables advanced to $81.4 million in Q4 2025 per CURLF's latest filing, from $68.8 million in the prior quarter.
  • Over the last five years, Receivables for CURLF reached as high as $66.8 billion in Q1 2022 and fell as low as -$4000.0 in Q1 2021.
  • A 5-year average of $5.2 billion and a median of $56.8 million in 2021 frame the typical range for Receivables.
  • Annual changes were most pronounced in 2022 — Receivables surged 1670225100.0% — and 2023, when it slumped 37.92%.
  • Year by year, Receivables stood at $2.4 million in 2021, then surged by 1961.76% to $50.0 million in 2022, then rose by 24.81% to $62.4 million in 2023, then rose by 10.22% to $68.8 million in 2024, then climbed by 18.44% to $81.4 million in 2025.
  • According to Business Quant data, Receivables over the past three periods registered $81.4 million, $68.8 million, and $62.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 2.99 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 3.39 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.51 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 6.46 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 312.00 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.29 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 3.58 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 768.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.15 Bn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 81.43 Mn
Dec 31, 2024 68.75 Mn
Dec 31, 2023 62.38 Mn
Sep 30, 2023 38.06 Mn
Jun 30, 2023 46.67 Mn
Dec 31, 2022 49.98 Mn
Sep 30, 2022 61.31 Mn
Jun 30, 2022 64.65 Mn
Mar 31, 2022 66.81 Bn
Dec 31, 2021 2.42 Mn
Sep 30, 2021 56.76 Mn
Jun 30, 2021 49.67 Mn
Mar 31, 2021 -4,000.00
Dec 31, 2020 15,000.00
Sep 30, 2020 -14.10 Mn
Mar 31, 2020 -14.60 Mn
Dec 31, 2019 -35.44 Mn
Sep 30, 2019 -24.00 Mn